Advertisement
DHR vs EXR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Buy and EXR is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 0 FA rating(s) are green whileEXR’s FA Score has 0 green FA rating(s).
- DHR’s FA Score: 0 green, 5 red.
- EXR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 4 TA indicator(s) are bullish while EXR’s TA Score has 6 bullish TA indicator(s).
- DHR’s TA Score: 4 bullish, 4 bearish.
- EXR’s TA Score: 6 bullish, 3 bearish.
Price Growth
DHR (@Medical Specialties) experienced а +1.59% price change this week, while EXR (@Real Estate Investment Trusts) price change was +3.71% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.31%. For the same industry, the average monthly price growth was +2.48%, and the average quarterly price growth was -2.30%.
The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +2.17%. For the same industry, the average monthly price growth was +2.91%, and the average quarterly price growth was -5.50%.
Reported Earning Dates
DHR is expected to report earnings on Jul 29, 2025.
EXR is expected to report earnings on Aug 05, 2025.
Industries' Descriptions
@Medical Specialties (+1.31% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Real Estate Investment Trusts (+2.17% weekly)A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.
| DHR | EXR | DHR / EXR | |
| Capitalization | 185B | 31B | 597% |
| EBITDA | 7.5B | 1.82B | 413% |
| Gain YTD | -16.898 | 1.952 | -866% |
| P/E Ratio | 43.86 | 30.96 | 142% |
| Revenue | 23.9B | 2.56B | 934% |
| Total Cash | 5.86B | 99.1M | 5,917% |
| Total Debt | 19.5B | 11.3B | 173% |
DHR | EXR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 64 | 48 | |
SMR RATING 1..100 | 78 | 80 | |
PRICE GROWTH RATING 1..100 | 63 | 54 | |
P/E GROWTH RATING 1..100 | 78 | 41 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (43) in the Medical Specialties industry is somewhat better than the same rating for EXR (83) in the Real Estate Investment Trusts industry. This means that DHR’s stock grew somewhat faster than EXR’s over the last 12 months.
EXR's Profit vs Risk Rating (48) in the Real Estate Investment Trusts industry is in the same range as DHR (64) in the Medical Specialties industry. This means that EXR’s stock grew similarly to DHR’s over the last 12 months.
DHR's SMR Rating (78) in the Medical Specialties industry is in the same range as EXR (80) in the Real Estate Investment Trusts industry. This means that DHR’s stock grew similarly to EXR’s over the last 12 months.
EXR's Price Growth Rating (54) in the Real Estate Investment Trusts industry is in the same range as DHR (63) in the Medical Specialties industry. This means that EXR’s stock grew similarly to DHR’s over the last 12 months.
EXR's P/E Growth Rating (41) in the Real Estate Investment Trusts industry is somewhat better than the same rating for DHR (78) in the Medical Specialties industry. This means that EXR’s stock grew somewhat faster than DHR’s over the last 12 months.
| DHR | EXR | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 68% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 59% | 2 days ago 72% |
| Advances ODDS (%) | 11 days ago 58% | 2 days ago 69% |
| Declines ODDS (%) | 17 days ago 58% | 9 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 69% | 2 days ago 46% |
| Aroon ODDS (%) | 2 days ago 49% | 2 days ago 65% |
Advertisement
EXR and
Correlation & Price change
A.I.dvisor indicates that over the last year, EXR has been closely correlated with PSA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if EXR jumps, then PSA could also see price increases.
| Ticker / NAME | Correlation To EXR | 1D Price Change % | ||
|---|---|---|---|---|
| EXR | 100% | +1.56% | ||
| PSA - EXR | 90% Closely correlated | +1.28% | ||
| CUBE - EXR | 89% Closely correlated | +1.57% | ||
| NSA - EXR | 84% Closely correlated | +1.42% | ||
| VICI - EXR | 72% Closely correlated | +0.44% | ||
| UDR - EXR | 71% Closely correlated | +1.55% | ||
More | ||||